Literature DB >> 31676347

Beyond intraocular pressure: Optimizing patient-reported outcomes in glaucoma.

Eva K Fenwick1, Ryan Ek Man1, Tin Aung2, Pradeep Ramulu3, Ecosse L Lamoureux4.   

Abstract

Glaucoma, an irreversible blinding condition affecting 3-4% adults aged above 40 years worldwide, is set to increase with a rapidly aging global population. Raised intraocular pressure (IOP) is a major risk factor for glaucoma where the treatment paradigm is focused on managing IOP using medications, laser, or surgery regimens. However, notwithstanding IOP and other clinical parameters, patient-reported outcomes, including daily functioning, emotional well-being, symptoms, mobility, and social life, remain the foremost concerns for people being treated for glaucoma. These outcomes are measured using objective patient-centered outcome measures (PCOMs) and subjective patient-reported outcome measures (PROMs). Studies using PCOMs have shown that people with glaucoma have several mobility, navigational and coordination challenges; reading and face recognition deficits; and are slower in adapting to multiple real-world situations when compared to healthy controls. Similarly, studies have consistently demonstrated, using PROMs, that glaucoma substantially and negatively impacts on peoples' self-reported visual functioning, mobility, independence, emotional well-being, self-image, and confidence in healthcare, compared to healthy individuals, particularly in those with late-stage disease undergoing a heavy treatment regimen. The patient-centred effectiveness of current glaucoma treatment paradigms is equivocal due to a lack of well-designed randomized controlled trials; short post-treatment follow-up periods; an inappropriate selection or availability of PROMs; and/or an insensitivity of currently available PROMs to monitor changes especially in patients with newly diagnosed early-stage glaucoma. We provide a comprehensive, albeit non-systematic, critique of the psychometric properties, limitations, and recent advances of currently available glaucoma-specific PCOMs and PROMs. Finally, we propose that item banking and computerized adaptive testing methods can address the multiple limitations of paper-pencil PROMs; customize their administration; and have the potential to improve healthcare outcomes for people with glaucoma.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computerized adaptive testing; Glaucoma; Glaucoma treatments; Patient-centred outcomes; Patient-reported outcomes; Quality of life

Mesh:

Substances:

Year:  2019        PMID: 31676347     DOI: 10.1016/j.preteyeres.2019.100801

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  8 in total

1.  Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains.

Authors:  Preeti Gupta; Eva K Fenwick; Ryan E K Man; Alfred T L Gan; Charumathi Sabanayagam; Debra Quek; Chaoxu Qian; Chui Ming Gemmy Cheung; Ching-Yu Cheng; Ecosse L Lamoureux
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

2.  Psychometric Evaluation of Glaucoma Quality of Life Item Banks (GlauCAT) and Initial Assessment Using Computerized Adaptive Testing.

Authors:  Ryan Eyn Kidd Man; Eva K Fenwick; Jyoti Khadka; ZhiChao Wu; Simon Skalicky; Konrad Pesudovs; Ecosse L Lamoureux
Journal:  Transl Vis Sci Technol       Date:  2022-06-01       Impact factor: 3.048

3.  Priorities and Treatment Preferences among Surgery-Naive Patients with Moderate to Severe Open-Angle Glaucoma.

Authors:  Amanda K Bicket; Jimmy T Le; Carol Yorkgitis; Tianjing Li
Journal:  Ophthalmol Glaucoma       Date:  2020-05-16

Review 4.  Role of glia in optic nerve.

Authors:  Meysam Yazdankhah; Peng Shang; Sayan Ghosh; Stacey Hose; Haitao Liu; Joseph Weiss; Christopher S Fitting; Imran A Bhutto; J Samuel Zigler; Jiang Qian; José-Alain Sahel; Debasish Sinha; Nadezda A Stepicheva
Journal:  Prog Retin Eye Res       Date:  2020-08-06       Impact factor: 21.198

Review 5.  Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection.

Authors:  Sentaro Kusuhara; Makoto Nakamura
Journal:  Clin Ophthalmol       Date:  2020-05-06

6.  Meta-Analysis of the Comprehensive Efficacy of Intraocular Lens Implantation in Glaucoma Patients.

Authors:  Qingyi Zhou
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

7.  The development of a glaucoma-specific health-related quality of life item bank supporting a novel computerized adaptive testing system in Asia.

Authors:  Eva K Fenwick; Belicia Lim; Ryan E K Man; Mani Baskaran; Monisha E Nongpiur; Chelvin C A Sng; Jayant V Iyer; Rahat Husain; Shamira A Perera; Tina T Wong; Jin Rong Low; Olivia Huang Shimin; Katherine Lun; Tin Aung; Ecosse L Lamoureux
Journal:  J Patient Rep Outcomes       Date:  2022-10-11

8.  Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM.

Authors:  Dao Wei Zhang; Shenghai Zhang; Jihong Wu
Journal:  PeerJ       Date:  2020-09-03       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.